Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Daniel Faga — FY2025 total compensation $6,133,943

Daniel Faga is President and Chief Executive Officer and Director of Anaptysbio, Inc (ANAB). The company reported total compensation of $6,133,943 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$706,011
Bonus$0
Stock awards$1,592,001
Option awards$3,345,653
Non-equity incentive plan$465,968
Pension and non-qualified deferred compensation$0
All other compensation$24,310
Total$6,133,943

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Anaptysbio, Inc filed June 29, 2026, accession 0001193125-26-288408.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer and Director$706,011$0$1,592,001$3,345,653$465,968$0$24,310$6,133,943
FY2024President and Chief Executive Officer and Director$685,448$0$6,889,127$5,723,455$308,452$0$23,810$13,630,292

Totals as disclosed in each year's own compensation disclosure for Anaptysbio, Inc.

03

Peer context

Peer-group chief executive median$6,110,875
Difference from that median$23,068
Percentile within the disclosed peer group50th
Peers with a disclosed figure7

Medians and percentiles are computed across the peer group Anaptysbio, Inc discloses in its own compensation disclosure.

04

The other named executive officers of Anaptysbio, Inc

Named executive officerRoleFY2025 total
Daniel Faga this pagePresident and Chief Executive Officer and Director$6,133,943
Paul LizzulChief Medical Officer$2,365,377
Dennis MulroyChief Financial Officer$2,007,927

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Anaptysbio, Inc compensation brief.

05

The company page

Daniel Faga's compensation sits inside Anaptysbio, Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Anaptysbio, Inc (ANAB) compensation brief